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ABSTRACT
Objectives: The aim of this study is to assess the effectiveness of pipelle in sampling diagnostic material from the uterine 
cavity and determining clinical factors, which may affect its effectiveness.
Material and methods: The retrospective analysis included 312 patients who underwent pipelle biopsy because of 
various indications. Evaluated factors which may affect the effectiveness of this method were: types of indications for the 
procedure, age, BMI, anteflexion or retroflexion of the uterus, presence of uterine fibroids, miscarriages, natural deliveries, 
deliveries in general.
Results: In 259 (83.01%) cases sampled material allowed for a histopathological diagnosis. In 53 (16.99%) of the women 
we failed to sample tissue material from the uterine cavity. Indications for the procedure, BMI, age and menopausal status 
were factors of potential impact on the diagnostic effectiveness (p < 0.05). The diagnostic value of pipelle was found to 
be the lowest in women with overweight and obesity (BMI > 28), post-menopausal women, women over 55 years of age 
and where biopsy was performed for indications other than abnormal uterine bleeding. On the other hand, pipelle shows 
clearly the highest effectiveness in sampling diagnostic material from the uterine cavity in young women (< 45 years of 
age), menstruating women, women with normal body weight or underweight (BMI < 23) and abnormal uterine bleeding.
Conclusions: Choosing a pipelle as an endometrial biopsy method should consider the indications, BMI, age and meno-
pausal status. Omission of these factors can increase non-diagnostic outcomes resulting in necessity of repeated biopsies, 
the risk of complications and increases the costs of health care system.
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INTRODUCTION
Biopsy of the endometrium is the principal method 
used to detect pathological changes in the uterine cavity. 
Diagnosis depends on obtaining adequate tissue material 
necessary for microscopic analysis. In everyday practice 
none of the methods used guarantees sampling an ad-
equate quantity of tissue. What should be taken into account 
in the choice of the diagnostic method is its sensitivity and 
specificity, easiness of performance, availability and accept-
ance by patients. The economic aspect cannot be neglected 
either. Absence of the need for general anaesthesia and 
a possibility of performing the procedure on an outpatient 
basis lower the cost, which is of importance in the economic 
climate of today.
Curettage of the uterine cavity is considered to be 
a method of choice in numerous clinical situations [1]. Yet, 
even this examination is no guarantee of obtaining diagnos-
tic material from the uterine cavity and thus giving a diag-
nosis [2]. It has been estimated that abrasion allows for the 
inspection of 50–60% of the uterine cavity surface while the 
percentage of non-diagnostic results reaches 3% [3–5]. This 
method, requiring general anaesthesia and hospitalization, 
entails a high risk of serious complications.
Over the past two decades, a few less invasive methods, 
among others, pipelle, tao brush, vabra, jet irrigation, have 
been introduced to increase the availability, reduce the num-
ber and incidence of complications as well as lower the costs 
endometrial pathology diagnostics [6–9]. Pipelle has become 
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of cases indications other than abnormal uterine bleeding 
were present. Detailed distribution of indications is given 
in Figure 1.
In 259 (83.01%) out of the 312 women in whom pipella 
was applied the final sampled material allowed for a histo-
pathological diagnosis. Normal endometrium was found in 
237 (75.96%) of patients, in 17 (6.56%) of cases endometrial 
hyperplasia was diagnosed and in 3 (0.96) endometrial can-
cer. In 53 (16.99%) of the women we failed to sample from 
the uterine cavity tissue material which would allow to make 
a diagnosis on histopathological examination. Detailed fig-
ures are presented in Figure 2.
Among the analysed factors of potential impact on the 
diagnostic effectiveness of pipelle the following were found 
to be of significance: indications for the procedure, BMI, age 
and menopausal status (p < 0.05) (Table 1).
The assessment of the influence of indications for the 
procedure on the diagnostic effectiveness of pipelle after 
sampling tissue material gave the following results. In the 
group of patients with abnormal uterine bleeding diagnos-
tic material was obtained in 133/151 (88.08%) while in the 
case of biopsies performed for indications other than uterine 
bleeding material for microscopic examination was ob-
tained in 126/151 (78.26%) of patients which constituted 
a significantly lower figure (p < 0.05).
The analysis of the influence of BMI on the effective-
ness of pipelle allowed to distinguish three prognostic 
groups. Most frequently diagnostic material was obtained in 
women with a BMI not exceeding 23. In this group adequate 
material was sampled in 79/87 (90.8%) of patients. In the 
group with a BMI of 23–28, 70/87 (80.46% diagnostic biop-
sies were recorded. The lowest percentage of positive results 
was found in the group of women with a BMI > 28 where it 
very popular due to its easiness and simplicity as well as its 
high sensitivity in detecting endometrial cancer [10–12].
The aim of this study is to assess the effectiveness of 
pipelle in sampling diagnostic material from the uterine 
cavity and determining clinical factors which may affect 
its effectiveness.
MATERIAL AND METHODS
The retrospective analysis included 312 patients who 
underwent pipelle biopsy because of various indications in 
the 1st Chair and Department of Obstetrics and Gynecology, 
Medical University of Warsaw, in the years 2013–2014. The 
study assessed the effectiveness of endometrial aspiration 
biopsy in sampling tissue material from the uterine cavity for 
histopathologic examination. To determine factors which may 
affect the effectiveness of this method the analysis covered: 
types of indications for the procedure, age, BMI, anteflexion 
or retroflexion of the uterus, presence of uterine fibroids, 
miscarriages, natural deliveries, deliveries in general.
The statistical analysis of the material was performed 
with the use of Statistica 12.0. In the analysis of measur-
able data (age, BMI), student t-test was used and, in the 
absence of normality, checked with Shapiro-Wilk W test, the 
Mann-Whitney U test was used. To evaluate the dependence 
of qualitative variables (shape of the uterus, presence of 
uterine fibroids, past uterine operations as well as proce-
dures in the uterine cavity, miscarriages, natural deliveries, 
deliveries in general) chi-square test was used. The signifi-
cance level adopted in all analyses was 0.05.
RESULTS
Abnormal uterine bleeding was the most common in-
dication for the procedure — 151 (48.4%). In 161 (51.6%) 
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Figure 1. Indications for endometrial aspiration biopsy with the use of pipelle. The most common indication for the performance of pipelle was 
abnormal uterine bleeding — 151 (48.4%). Other indications for the procedure included: abnormal USG image — 48 (15.38%), cervical polyp — 34 
(10.9%), state after simple hyperplasia — 33 (10.58%), cervical dysplasia — 32 (10.26%), pre-operative examination — 8 (2.56%) and diagnostics of 
abortions, infertility, irregular menstruations — 5 (1.6%)
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in the > 55 age group in 44/75 (58.67%) of women. The dif-
ferences observed between the groups were statistically 
significant (p < 0.05).
The menopausal status of the women was another pa-
rameter analysed. Diagnostic biopsies were most common 
in the pre-menopausal group of patients where tissue mate-
rial from the uterine cavity was obtained in 183/193 (94.82%) 
women. In peri-menopausal and post-menopausal patients 
the effectiveness was lower, diagnostic biopsies being ob-
tained in 19/27 (70.37%) and 56/91 (61.54%), respectively 
(p < 0.05).
The study did not reveal the influence of other factors 
on the effectiveness of pipelle in sampling tissue material 
reached 63/82 (76.83%). The differences between the groups 
were statistically significant at p < 0.05.
The age criterion allowed to distinguish three groups 
of patients, the first being women < 45 years of age, the 
second women between 45 and 55 years of age and the 
third women > 55 years of age. The effectiveness of biopsy 
performed with the use of the pipelle device was the high-
est in the group of patients over 45 years of age where 
material for microscopic examination was obtained from 
125/130 (96.15%) of the women. In older patients, the ef-
fectiveness of this method of sampling biopsy material was 
lower. In the 45–55 age group diagnostic biopsies were 
successfully performed in 91/107 (85.05%) of patients while 
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Figure 2. Distribution of results of histopathological examination obtained with the use of pipelle. In 23 cases no endometrial pathology was 
found, in 17 endometrial hyperplasia was diagnosed and in 3 endometrial cancer was detected. In 53 women no tissue material from uterine cavity 
was obtained
Table 1. Characteristic of the study group
Factors affecting the effectiveness of pipelle biopsy Percentage  of non-diagnostic biopsies (%) Chi-square test
Type of indication for the procedure
Abnormal uterine bleeding 11.51
P < 0.05
Other 21.74
BMI
< 23 9.19
23–28 19.5 P < 0.05
> 28 23.17
Age
< 45 yrs. 3.85
45–55 yrs. 14.95 P < 0.001
> 55 yrs. 41.33
Menopausal status 
Menstruating 5.18
Peri-menopausal 29.63 P < 0.001
Post-menopausal 38.46
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for histopathological examination. Anteflexion of the uterus 
was found to be associated with a slightly higher percentage 
of effective biopsies than retroflexion (84.94% vs. 80.49%, 
p = 0.61). The presence of fibroids in the uterus can have 
an adverse impact on sampling material from the uterine 
cavity (79.55% vs. 83.96%), however this does not constitute 
a statistically significant difference (p = 0.47). Past history of 
operations on the uterus or procedures within the uterine 
cavity was of no impact on sampling material from the 
cavity, 80.43% vs. 83.52% (p = 0.6) and 84.03% vs. 79.59% 
(p = 0.44). In nulliparas, the percentage of diagnostic bi-
opsies was higher but not in a statistically significant way 
(89.29% vs. 82.03%, p = 0.19).
DISCUSSION
Early detection of pre-neoplastic and neoplastic chang-
es remains the principal aim of endometrial diagnostics. Less 
invasive techniques which can be applied in an outpatient 
setting play a primary role these days. Pipelle endometrial 
biopsy seems to enjoy the greatest popularity among them 
[10–12]. Though a mere 4.2% of the uterine cavity surface 
can be inspected during its performance, the sensitivity and 
specificity of pipelle in detecting hyperplasia and atypia are 
comparable with abrasion and reach 67% and 75%, respec-
tively [10, 13]. In the case of abrasion, they are 62% and 83%, 
respectively [13]. Pipelle biopsy is also characterized by high 
sensitivity in detecting endometrial neoplasms (93.8–99.2%) 
[14]. Lack of need for general anaesthesia, reduced duration 
of the diagnostic procedure, cost reduction and decrease 
in the number and incidence of complications constitute 
no doubt further significant advantages of this diagnostic 
method [15].
The way in which material is sampled from the uterine 
cavity with the use of this method may reduce its effective-
ness in obtaining a reliable quantity of tissue material for mi-
croscopic examination. Different authors report a percent-
age of non-diagnostic examinations of between 3 and 16% 
[13, 16–18]. In their meta-analysis Dijkuzen et al. estimated 
that 10.4% of pipelle biopsies involve ineffective sampling 
of uterine cavity material [4]. In our study, the percentage 
of ineffective pipelle biopsies was 16.99%.
An additional aim of the study was to determine factors 
which may have an influence on the effectiveness of pipelle. 
Like in the study by Williams et al. important factors proved 
to be the age of patients and their menopausal status strictly 
linked to it [19]. In women with atrophic endometrium 
the thickness of which on USG examination was < 5 mm 
the effectiveness of pipelle biopsy in obtaining adequate 
material from the uterine cavity is merely 27% [20]. On the 
other hand, Williams et al. report that the percentage of 
non-diagnostic results in women with AUB after menopause 
was 48% while in women over 54 years of age it is even 
higher and reaches 58% [19]. In our study, the diagnos-
tic effectiveness of pipelle biopsy was also the lowest in 
post-menopausal women and in the age group > 55 years 
of age, reaching 38.46% and 41.33%, respectively. The dif-
ferences in the obtained results can be explained with dif-
ferences in the population groups studied. We analysed 
pipelle biopsies performed for all indications, not only for 
abnormal uterine bleeding.
It seems that when the indication for biopsy is other 
than abnormal uterine bleeding, the use of another diag-
nostic method may be a better choice. However, due to the 
high diversity of our study group (as many as 6 different 
indications — abnormal USG image of the endometrium, 
polyp of the cervix, state after treatment of endometrial hy-
perplasia, cervical dysplasia, diagnostics prior to a planned 
surgical procedure, spontaneous abortion diagnostics, in-
fertility, irregular menstruation) we find it difficult to point 
out in what types of indications pipelle biopsy is clearly 
a bad choice as a method of first choice and where it may 
be considered. What arouses our greatest doubts is the 
performance of pipelle biopsy as a check-up after treatment 
of endometrial hyperplasia, in particular with atypia. Failure 
to obtain diagnostic material may then become a cause of 
unnecessary stress and uncertainty for women and of delays 
in further management where treatment proves ineffective.
In our study, we showed that performance of endo-
metrial aspiration biopsy for indications other than AUB is 
linked to a higher percentage of non-diagnostic biopsies 
(21.74% vs. 11.51%). In the studies referred to, their authors 
investigated the effectiveness of pipelle biopsy but in their 
analyses they did not take into account the influence of 
individual types of indications on the effectiveness of the 
method. The majority of the studies concerns pipelle biop-
sies performed because of abnormal uterine bleeding. Ko-
rean authors assessed the effectiveness of sampling material 
from the uterine cavity in which LNG-IUS was placed. They 
showed that inadequate material was harvested in as much 
as 60.7% [19]. What attracts attention is the heterogeneity 
of the study group with as many as 8 types of indications 
(abnormal USG image of the endometrium, polyp of the 
uterine cervix, state after endometrial hyperplasia, dysplasia 
of the uterine cervix, diagnostics prior to a planned surgical 
procedure, diagnostics of spontaneous abortions, infertility, 
irregular menstruations). Further studies on larger groups of 
women are needed to determine which of the indications 
listed are of major impact on the diagnostic effectiveness 
of pipelle biopsy.
A factor of significant consequence for the diagnostic ef-
fectiveness of pipelle biopsy, not described in earlier studies, 
is BMI. In our study, we registered the highest percentage of 
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failed biopsies in obese and overweight women (BMI > 28). 
This can be explained in terms of technical difficulties with 
performing the procedure. However, we found significantly 
worse effectiveness in women with BMI 23–28 while ob-
taining the best effectiveness in the group of patients with 
BMI < 23. This factor requires being checked in more detail 
in subsequent studies. Importantly, in none of the articles 
referred to was this parameter studied as a factor of poten-
tial influence on the effectiveness of pipelle biopsy. BMI is 
a parameter easy to calculate in everyday clinical practice 
and its inclusion can increase the percentage of results of 
no diagnostic value while at the same time eliminate the 
necessity of repeating the examination in the case of failure 
to obtain material for microscopic examination.
Williams et al. report nulliparity being a factor of adverse 
effect for the diagnostic effectiveness of pipelle biopsy [19]. 
Among women who gave birth to a child the percentage of 
results of no diagnostic value was 5% while in the group of 
nulliparas it reached 25%. These results were independent 
of the ability to enter the uterine cavity as well as statisti-
cally significant (p < 0.001). Our findings do not confirm this 
dependence. The percentage of non-diagnostic results in 
nulliparas was 10.71% (6/56 of cases). On the other hand, in 
child-bearing women it was 17.9% (46/256 of cases). How-
ever this difference was not statistically significant (p = 0.18).
The principal aim of endometrial diagnostics is to detect 
a malicious neoplasm and pathologic hyperplasia. Over the 
past years we have been observing growth in the incidence 
of endometrial cancer among women of post-menopausal 
age [21, 22]. So far no screening method which would help 
detect early forms of this neoplasm has been proved to ex-
ist. This is precisely what makes it extremely important to 
have a possibility to apply an effective diagnostic method 
in the case of the presence of risk factors or on the appear-
ance of disquieting symptoms. It turns out that otherwise 
commonly known endometrial cancer risk factors such as 
obesity, advanced age or menopausal status can also be fac-
tors of negative influence on the diagnostic effectiveness of 
pipelle biopsy. In these cases, curettage of the uterine cavity 
seems to be able to accelerate diagnosis and thus treatment. 
On the other hand, patients with endometrial cancer risk 
factors are women with numerous internal medicine co-
morbidities, requiring numerous consultations, additional 
examinations and time for adequate preparation for general 
anaesthesia and abrasion. In cases of this kind, pipelle biopsy 
can constitute a method of first choice, in particular when 
the time of waiting for the result of a histopathological 
examination is several days.
All methods of the endometrial biopsy are related to the 
possibility of various complications. Pain is the most com-
monly reported by women undergoing aspiration biopsy. It 
has been demonstrated that pipelle endometrial sampling 
compared to D & C biopsy is associated with less pain [10, 
15]. Other study concluded that pipelle significantly produ-
ced more pain than D & C and higher overall discomfort [23]. 
It has been shown that the frequency and severity of pain is 
closely associated with the use tenaculum during inserting 
a pipelle into the uterine cavity. Using the tenaculum was 
found to increase the risk of painful biopsy 32-fold [24]. 
Therefore it is recommended not to use tenaculum, unless 
it is necessary for the biopsy.
The highest risk of serious complications occurs at D & C 
biopsy and it is estimated at 0.6–1.3% for perforation, 0.3– 
–0.5% for infections, 0.4% for bleeding/haemorrhage [25, 26]. 
Endometrial sampling with pipelle device reduced incidence 
of serious complications [27]. Although our study did not 
report any uterine muscle damage, pelvic infection or other 
complications, it is estimated that the risk of perforation 
during pipelle biopsy is 0.1–0.2% [28]. One of the most 
severe complication was the case of large pelvic abscess 
following uterine perforation in a 53-year-old woman after 
endometrial pipelle sampling [29]. Loops of the large bowel 
were encased in the abscess. Despite the use a broad spec-
trum antibiotics (ampicillin, gentamicin, clindamycin) no 
improvement of the general condition has been reported. 
Women required surgical treatment — modified radical 
hysterectomy, bilateral adnexectomy, lysis of adhesions 
and partil colon resection with end-to-end anastomosis 
were performed. Although pipelle endometrial sampling is 
a minimally invasive procedure, clinicians always should be 
aware of the existing risks of serious complications.
Endometrial aspiration biopsy with the use of pipelle 
is a diagnostic method alternative to abrasion. The devel-
opment of the outpatient diagnostics of endometrial pa-
thologies increases the availability of this examination to 
the population at large, shortens the time and is evidently 
cost-effective. Knowledge of factors of potential influence 
on the effectiveness of pipelle biopsy in obtaining diag-
nostic material can make proper qualification easier for 
gynecologists.
We would recommend to commence diagnostics with 
pipelle biopsy in women < 45 years of age, with abnormal 
uterine bleeding, before menopause and with normal BMI. On 
the other hand, in asymptomatic patients, obese, elder and 
non-menstruating women it seems better to begin the diag-
nostic procedure with a method other than pipelle biopsy.
A larger number of studies on factors of potential in-
fluence on the effectiveness of pipelle biopsy is obviously 
necessary to determine beyond any doubt which diagnostic 
method would constitute the best choice for a given patient. 
In particular, this concerns factors for which statistical sig-
nificance was not assessed. 
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CONCLUSIONS
The diagnostic effectiveness of pipelle in sampling diag-
nostic material depends on the types of indications for the pro-
cedure, BMI, age and menopausal status. Its diagnostic value 
can decrease significantly when a few adverse factors overlap. 
The diagnostic value of pipelle was found to be the 
lowest in women with overweight and obesity (BMI > 28), 
post-menopausal women, women over 55 years of age and 
where biopsy was performed for indications other than ab-
normal uterine bleeding.
On the other hand, pipelle shows clearly the highest ef-
fectiveness in sampling diagnostic material from the uterine 
cavity in young women (< 45 years of age), menstruating 
women, women with normal body weight or underweight 
(BMI < 23) and abnormal uterine bleeding.
We can also distinguish a group of women in whom 
pipelle shows indirect effectiveness in sampling tissue mate-
rial, namely, patients aged 45 to 55 years, in peri-menopausal 
period, with a BMI coefficient of 23–28.
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